Related Experiment Video
Updated: Oct 17, 2025
Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
A Systematic Strategy to Find Potential Therapeutic Targets for Pseudomonas aeruginosa Using Integrated Computational
Fernando Medeiros Filho1, Ana Paula Barbosa do Nascimento1, Maiana de Oliveira Cerqueira E Costa2
1Programa de Computação Científica, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Abstract:
Pseudomonas aeruginosa is an opportunistic human pathogen that has been a constant global health problem due to its ability to cause infection at different body sites and its resistance to a broad spectrum of clinically available antibiotics. The World Health Organization classified multidrug-resistant Pseudomonas aeruginosa among the top-ranked organisms that require urgent research and development of effective therapeutic options. Several approaches have been taken to achieve these goals, but they all depend on discovering potential drug targets. The large amount of data obtained from sequencing technologies has been used to create computational models of organisms, which provide a powerful tool for better understanding their biological behavior. In the present work, we applied a method to integrate transcriptome data with genome-scale metabolic networks of Pseudomonas aeruginosa. We submitted both metabolic and integrated models to dynamic simulations and compared their performance with published in vitro growth curves. In addition, we used these models to identify potential therapeutic targets and compared the results to analyze the assumption that computational models enriched with biological measurements can provide more selective and (or) specific predictions. Our results demonstrate that dynamic simulations from integrated models result in more accurate growth curves and flux distribution more coherent with biological observations. Moreover, identifying drug targets from integrated models is more selective as the predicted genes were a subset of those found in the metabolic models. Our analysis resulted in the identification of 26 non-host homologous targets. Among them, we highlighted five top-ranked genes based on lesser conservation with the human microbiome. Overall, some of the genes identified in this work have already been proposed by different approaches and (or) are already investigated as targets to antimicrobial compounds, reinforcing the benefit of using integrated models as a starting point to selecting biologically relevant therapeutic targets.
Insights
This study integrates transcriptome data with metabolic models of Pseudomonas aeruginosa to identify new drug targets. Integrated models provide more accurate predictions and identify selective targets for antimicrobial development.
Area of Science:
- Microbiology
- Computational Biology
- Drug Discovery
Background:
- * *Pseudomonas aeruginosa* is a multidrug-resistant opportunistic pathogen causing significant global health concerns.
- * The World Health Organization highlights the urgent need for new therapeutic strategies against this bacterium.
- * Discovering novel drug targets is crucial for developing effective treatments.
Purpose of the Study:
- * To integrate transcriptome data with genome-scale metabolic networks of *Pseudomonas aeruginosa*.
- * To evaluate the predictive accuracy of integrated computational models compared to metabolic models alone.
- * To identify and prioritize potential therapeutic targets using these enhanced models.
Main Methods:
- * Integration of *Pseudomonas aeruginosa* transcriptome data with genome-scale metabolic networks.
- * Dynamic simulations performed on both metabolic and integrated models.
- * Comparison of simulation results with published *in vitro* growth curves and identification of drug targets.
Main Results:
- * Dynamic simulations from integrated models yielded more accurate growth curves and biologically coherent flux distributions.
- * Drug target identification using integrated models was more selective, yielding a subset of targets from the metabolic models.
- * 26 non-host homologous targets were identified, with five top-ranked genes showing minimal conservation with the human microbiome.
Conclusions:
- * Integrated computational models enriched with biological measurements offer more selective and specific predictions for drug target discovery.
- * The identified targets, including five prioritized genes, represent promising starting points for developing new antimicrobial compounds.
- * This approach validates the utility of integrated models in identifying biologically relevant therapeutic targets for *Pseudomonas aeruginosa*.
